Comparison of distribution characteristics of metastatic bone lesions between breast and prostate carcinomas

Oncology Letters

Volumn 5, Issue 1, 2012, Pages 391-397

  Wang, Chang Yin ^a   Wu, Guang Yao ^a   Shen, Mei Juan ^a   Cui, Kun Wei ^a   Shen, Ying ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Bone scan; Breast neoplasms; Neoplasm metastasis; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BREAST CARCINOMA; COMPARATIVE STUDY; FEMALE; FEMUR; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PELVIS; PROSTATE CARCINOMA; RIB; SKULL; STERNUM; THORACIC SPINE;

EID: 84869015251     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1005     Document Type: Article

References (18)

1. Lin K, Szabo Z, Chin BB and Civelek AC: The value of a baseline bone scan in patients with newly diagnosed prostate cancer. Clin Nucl Med 24: 579-582, 1999.
2. Conti G, La Torre G, Cicalese V, et al: Prostate cancer metastases to bone: Observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline features. Arch Ital Urol Androl 80: 59-64, 2008.
3. Maffioli L, Florimonte L, Pagani L, Butti I and Roca I: Current role of bone scan with phosphonates in the follow-up of breast cancer. Eur J Nucl Med Mol Imaging 31 (Suppl 1): S143-S148, 2004.
4. 99mTc-diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases. Am J Roentgenol Radium Ther Nucl Med 125: 972-977, 1975.
5. Tofe AJ, Francis MD and Harvey WJ: Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1355 diphosphonate bone scans. J Nucl Med 16: 986-989, 1975.
6. Wilson MA and Calhoun FW: The distribution of skeletal metastases in breast and pulmonary cancer: concise communication. J Nucl Med 22: 594-597, 1981.
7. Huang CY, Hsu HC, Chang CH, Tseng KF and Fong YC: Prostate cancer with bone metastases: a clinical pofile. Mid Taiwan J Med 11: 82-89, 2006.
8. Picchio M, Spinapolice EG, Fallanca F, Crivellaro C, Giovacchini G, Gianolli L and Messa C: [11C] Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy. Eur J Nucl Med Mol Imaging 39: 13-26, 2012.
9. Jacobson AF, Stomper PC, Jochelson MS, Ascoli DM, Henderson IC and Kaplan WD: Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer. J Nucl Med 31: 387-392, 1990.
10. Mohammadzadeh M, Alikhah H and Zareh AG: Comparison of bone scan with carbohydrate antigen 15-3 for evaluation of bone metastasis of breast cancer. Pak J Biol Sci 13: 175-179, 2010.
11. 18F-fluoride PET/CT. J Nucl Med 47: 287-297, 2006.
12. Gate GF: SPECT bone scanning of the spine. Semin Nucl Med 28: 78-94, 1998.
13. Even-Sapir E, Martin RH, Barnes DC, Pringle CR, Iles SE and Mitchell MJ: Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology 187: 193-198, 1993.
14. m methylene diphosphonate whole-body bone scans. Chinese-German J Clin Oncol 9: 435-440, 2010.
15. Cook GJ, Venkitaraman R, Sohaib AS, et al: The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer. Eur J Nucl Med Mol Imaging 38: 7-13, 2011.
16. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593, 2002.
17. Bubendorf L, Schöpfer A, Wagner U, et al: Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31: 578-583, 2000.
18. Ohtake E, Murata H and Maruno H: Bone scintigraphy in patients with breast cancer: malignant involvement of the sternum. Radiat Med 12: 25-28, 1994.